Clinical Trial Update: Prevention of Cognitive Decline in Older Adults With Low Dha/Epa Index in Red Blood Cells [Phase 3]

View source ↗

Summary

Phase 3 trial investigating prevention of cognitive decline in older adults with low DHA/EPA index in red blood cells for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED